Abstract:Triple‐negative breast cancer (TNBC) is a malignant tumor with high degree of malignancy and lack of effective target treatment. The research aims to explore the role and mechanism of X collagen alpha‐1 chain protein (COL10A1 gene) in TNBC. UALCAN and Kaplan–Meier were used to detect the expression of COL10A1 and its role in the prognosis of breast cancer patients. The cells with stably expressing high levels of COL10A1 were obtained by recombinant lentivirus infection. The expression of COL10A1 in cells was temporarily downregulated by siRNA interference fragments. Real‐time quantitative polymerase chain reaction and western blot analysis were utilized to detect the changes of COL10A1 mRNA and protein expression. The biological functions of the cells were evaluated by colony formation, cell counting kit‐8, cell invasion and wound healing experiments. In addition, the effect of COL10A1 on angiogenesis was investigated by tube formation assay. Xenograft tumor model was used to confirm the effect of COL10A1 on tumorigenicity in vivo and multiplex fluorescent immunohistochemistry to detect multiple proteins simultaneously. The possible molecular mechanism of the function of COL10A1 was speculated through the detection of proteins in functionally related pathways. COL10A1 is highly expressed and is significantly associated with worse overall survival (OS) and recurrence‐free survival (RFS) in TNBC. Overexpression of COL10A1 increased the clone formation rate and cell migration capacity of TNBC cells. In the COL10A1 overexpression group, the clone formation rates of MD‐MB‐231 and BT‐549 cells (21.5 ± 0.62, 27.83 ± 3.72)% were significantly higher than those in the control group(15.23 ± 2.79, 19.4 ± 1.47)%, and the relative migration ratio (47.40 ± 3.09, 41.26 ± 4.33)% were higher than those in the control group (34.48 ± 2.03, 21.80 ± 1.03)%. When the expression of COL10A1 was downregulated, the ability of clone formation and wound‐healing migration capacity in TNBC cells was weakened. Upregulated COL10A1 in TNBC cells generated more junctions and longer total segments between vascular endothelial cells, and promoted angiogenesis of the cells, and thus enhanced the tumorigenesis. In TNBC, it was found that COL10A1 might affect epithelial‐mesenchymal transition (EMT) of the cells through Wnt/β‐catenin signaling pathway by the detection of the related pathway proteins. COL10A1 is highly expressed in TNBC, and its high expression leads to poor OS and RFS. COL10A1 may enhance TNBC cell proliferation, migration and tumor‐related angiogenesis, and promote tumorigenesis in vivo via Wnt/β‐catenin signaling.

Collagen XVII inhibits breast cancer cell proliferation and growth through deactivation of the AKT/mTOR signaling pathway

Collagen XVII regulates tumor growth in pancreatic cancer through interaction with the tumor microenvironment

Collagen XVII promotes dormancy of colorectal cancer cells by activating mTORC2 signaling

Identification of a novel p53 target, COL17A1, that inhibits breast cancer cell migration and invasion

Targeting collagen XVIII improves the efficiency of ErbB inhibitors in breast cancer models

The potential role of collagen type VII in breast cancer proliferation

Overexpression of COL11A1 confers tamoxifen resistance in breast cancer

Collagen XV Mediated the Epithelial-Mesenchymal Transition to Inhibit Hepatocellular Carcinoma Metastasis

Regulation of collagen type XVII expression by miR203a-3p in oral squamous cell carcinoma cells

Deletion of Col15a1 Modulates the Tumour Extracellular Matrix and Leads to Increased Tumour Growth in the MMTV-PyMT Mouse Mammary Carcinoma Model

The inhibitory effects of COL1A2 on colorectal cancer cell proliferation, migration, and invasion

Membrane associated collagen XIII promotes cancer metastasis and enhances anoikis resistance

Prognostic and therapeutic implications of tumor-restrictive type III collagen in the breast cancer microenvironment

Recombinant humanized collagen type III with high antitumor activity inhibits breast cancer cells autophagy, proliferation, and migration through DDR1

Elevated collagen-I augments tumor progressive signals, intravasation and metastasis of prolactin-induced estrogen receptor alpha positive mammary tumor cells

COL5A1 promotes triple-negative breast cancer progression by activating tumor cell-macrophage crosstalk

Silencing of COL3A1 Represses Proliferation, Migration, Invasion, and Immune Escape of Triple Negative Breast Cancer Cells Via Down-Regulating PD-L1 Expression

Upregulation of collagen type X alpha 1 promotes the progress of triple‐negative breast cancer via Wnt/β‐catenin signaling

Increased Collagen Type V α2 (COL5A2) in Colorectal Cancer is Associated with Poor Prognosis and Tumor Progression

COX-2 modulates mammary tumor progression in response to collagen density

The COL7A1/PI3K/AKT axis regulates the progression of cholangiocarcinoma